about
A novel mRNA binding protein complex promotes localized plasminogen activator inhibitor-1 accumulation at the myoendothelial junction.IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects.Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome.Chronic kidney disease predicts long-term mortality after major lower extremity amputation.Effect of metabolic syndrome on the response to arterial injuryConnection between telomerase activity in PBMC and markers of inflammation and endothelial dysfunction in patients with metabolic syndrome.Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.Identification of genes whose expression is altered by obesity throughout the arterial tree.Resveratrol prevents high fat/sucrose diet-induced central arterial wall inflammation and stiffening in nonhuman primates.Impact of obesity on the expression profile of natriuretic peptide system in a rat experimental model.The 3'-UTR of the adiponectin Q gene harbours susceptibility loci for atherosclerosis and its metabolic risk traits.How do high glycemic load diets influence coronary heart disease?Offspring subcutaneous adipose markers are sensitive to the timing of maternal gestational weight gain.The mechanism by which moderate alcohol consumption influences coronary heart disease.Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies.Prolonged diet induced obesity has minimal effects towards brain pathology in mouse model of cerebral amyloid angiopathy: implications for studying obesity-brain interactions in mice.Differential changes in vascular mRNA levels between rat iliac and renal arteries produced by cessation of voluntary runningMechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes.The influence of metabolic syndrome on hemodialysis access patency.Inflammatory "adiposopathy" in major amputation patients.Masked hypertension in obesity: potential predictors and arterial damage.Metabolic syndrome is associated with type II endoleak after endovascular abdominal aortic aneurysm repair.Inflammatory mediators involved in the progression of the metabolic syndrome.Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.Significance of endothelial dysfunction in sleep-related breathing disorder.Active ingredients of traditional Chinese medicine in the treatment of diabetes and diabetic complications.Endothelial dysfunction in metabolic and vascular disorders.The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen).Correlates of reactive hyperemic index in men and postmenopausal women.Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications.Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration.Induced Pluripotent Stem Cell-Derived Endothelial Cells in Insulin Resistance and Metabolic Syndrome.Rat models of cardiometabolic diseases: baseline clinical chemistries, and rationale for their use in examining air pollution health effects.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.Adiponectin improves coronary no-reflow injury by protecting the endothelium in rats with type 2 diabetes mellitus.Chemerin connects fat to arterial contraction.Neuroinflammation is not a Prerequisite for Diabetes-induced Tau Phosphorylation.Dietary strawberries increase the proliferative response of CD3/CD28-activated CD8⁺ T cells and the production of TNF-α in lipopolysaccharide-stimulated monocytes from obese human subjects.Cardiovascular disease among patients with type 2 diabetes: Role of Homocysteine as an inflammatory marker.The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders.
P2860
Q30419477-E7FE0AD0-32A0-4CF9-BF37-E6FF8BF4EB89Q33740028-0385BF43-7AB6-47F9-A3CD-7C0DB238BD8AQ33864726-ED3BDF38-6B18-4E25-A9D6-ABAD52E48B3FQ33964613-DD5C2ABE-4A13-47DE-A086-C8B24DF411F5Q34052946-7753AAF1-0951-46E0-BA18-0C44E82461BDQ34256706-CDE12BC4-87DD-41FE-A2BC-9865A3ACE490Q34469009-86553471-36ED-453B-ADFF-ED263ED00583Q34519267-0F0BA8A0-0F45-4D17-A99C-6254653A74A4Q34624641-FCC45F9B-80E2-41E1-8C22-3F7E6D184E02Q34979675-941A1EA1-6213-4737-85F5-3C10B759494FQ35065404-2026495F-E646-4142-A30B-DFFDECA8E1E5Q35177141-F32FD48A-2898-4D4E-9E44-A4CFDE1559E4Q35186748-242B3622-DA2B-4913-9B17-92AFF0DAA1E6Q35315854-E93401DD-B551-46FA-9FD0-2C434268664CQ35898326-7EFA7107-8E43-413E-A2EF-C040BD0DAD14Q36051462-F7ABEFC1-A717-4FEB-B853-E407F3EF033CQ36328554-287574DE-9A53-4EA0-99DF-1633B660CD0BQ36341246-9217301A-916A-4102-A38B-ABEBCE9AF9B1Q36428005-5468A7E7-5C13-4553-A329-782A05C99237Q36702097-59C68F5D-A9F1-478D-A13B-2AFC4F5D1D80Q37557958-22DA5469-7112-47BA-A3CF-2278CC78DC88Q37666027-A21CC73F-2725-4C95-A903-0CE84D02275CQ37990459-86E26069-3F9B-49A9-ACB4-FBFD905A17D4Q38003113-A69B0FAA-733A-4A6B-8355-2844CF8BA4B8Q38019948-79543362-BD0F-45F6-B1B6-EA335900B600Q38031979-BF1F1202-35E3-4942-8283-902A6D54B03FQ38200828-02D2D6F1-D4B8-450B-8E7D-99298E5E3082Q38261764-31C5D034-9F57-4FAF-94B1-ED15DAF1687AQ38440350-B1C59A5C-75F9-477E-AAF1-ACDDBFF7D7F9Q38444730-3B875F67-B8C4-45E8-ADE4-01BB611A6A50Q38515285-5C5FEF0E-11DC-4410-9845-EF22890C2A13Q38669207-3D8F4237-5CDC-4973-9000-330A635619EBQ38669259-E832D8C6-EA75-4433-9364-C1F8A7820E50Q39042377-5DD7A23C-B60C-47EA-84B7-9137EDD69E66Q41138938-CAA70FEB-2500-4D19-ADBD-8609D5F7C711Q42267936-5B3930A9-B4EC-43C4-8351-248FC1333D97Q43184034-743D2344-8976-4E70-B329-BEC0059585A3Q45917458-C429A83B-907C-4D1A-B5E1-E2467353FAE8Q47672340-3C214027-3791-4995-A75E-4A9264EB7025Q51111797-44F27BBD-CEC5-4156-80BA-8D4F453CD78D
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vascular biology of metabolic syndrome
@ast
Vascular biology of metabolic syndrome
@en
type
label
Vascular biology of metabolic syndrome
@ast
Vascular biology of metabolic syndrome
@en
prefLabel
Vascular biology of metabolic syndrome
@ast
Vascular biology of metabolic syndrome
@en
P2860
P1476
Vascular biology of metabolic syndrome
@en
P2093
Daynene Vykoukal
Mark G Davies
P2860
P304
P356
10.1016/J.JVS.2011.01.003
P577
2011-03-24T00:00:00Z